May 9, 2025- The U.S. Commerce Department’s Section 232 investigation into semiconductor imports could create substantial new costs for the medtech sector if it brings additional tariffs, especially for medical devices that are chip-intensive or produced at a large scale, according to MedTech Dive. Tariffs threaten to disrupt the supply chains that underpin the semiconductor industry, according to the Wall Street Journal. Decades of predictable trade rules have made it easy for chip makers to design products in the U.S. and Europe, send them for fabrication to Taiwan or South Korea and ship them to China or elsewhere in Asia for assembly, according to the Wall Street Journal.